Expression and clinical significance of apolipoprotein D in epithelial ovarian carcinomas.

Keywords

Apolipoprotein B, Immunohistochemistry, Medicine, Clinical significance, Pathology

References

• Expression and prognostic significance of apolipoprotein D in breast cancer.Irene Diez‐Itza, Francisco J. Vizoso, A.M. Merino — 1994
• Aging and development of ovarian epithelial carcinoma: the relevance of changes in ovarian stromal androgen production.Margaret A. Thompson, Mark Adelson — 1993
• Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease.Milagros Balbı́n, José M.P. Freije, Antonio Fueyo — 1990
• Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study.Marcel Cardillo, Elisa Petrangeli, N Aliotta — 1998
• BMDP statistical softwareThomas A. Bubolz, W. J. Dixon — 1983
• Identification of the major protein components in breast secretions from women with benign and malignant breast diseases.Luis Sánchez‐Pulido, Francisco J. Vizoso, Irene Diez‐Itza — 1992
• Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells.Yolanda S. López-Boado, Jorge Tolivia, Carlos López-Otı́n — 1994
• Cloning and expression of human apolipoprotein D cDNA.Dennis Drayna, Ceri A. Fielding, J W McLean — 1986
• Problems of Convergence of Maximum Likelihood Iterative Procedures in Multiparameter SituationsNathan Mantel, Max H. Myers — 1971
• Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast culturesPierre R. Provost, Yves L. Marcel, Ross W. Milne — 1991
• Cancer statistics, 1992C. C. Boring, T. S. Squires, T. Tong — 1992
• Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells.Jacques Simard, Yvan de Launoit, Darrow E. Haagensen — 1992
• An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors.S. Chadha, B. Ramanath Rao, Ben J. Slotman — 1993
• Cancer statistics, 1995Phyllis A. Wingo, T. Tong, S. Bolden — 1995
• Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone.Dwight E. Saunders, Carl Christensen, J.R. Williams — 1995
• The Immunopathology of Gross Cystic Disease Fluid ProteinsGwen Mazoujian, Darrow E. Haagensen — 1990
• Interleukin‐6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin‐1α on apolipoprotein D and GCDFP‐15 expression in human breast cancer cellsYves Blais, Keiko Sugimoto, Marie‐Claude Carrière — 1995
• Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein systemW.J. McConathy, Petar Alaupovic — 1973
• Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells.Daniel R. Ciocca, David J. Adams, Dean P. Edwards — 1983
• Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.H. A. Risch — 1999

Cited by

• Apolipoprotein Concentrations Are Elevated in Malignant Ovarian Cyst Fluids Suggesting That Lipoprotein Metabolism Is Dysregulated in Epithelial Ovarian CancerVincenazo Zeno-zencovich — 2013
• Expression microarray analysis of brain tumors: what have we learned so far.Stephen Hunter — 2002
• Androgens and androgen receptor in prostate and ovarian malignancies.Marianne D. Sadar — 2003
• Apolipoprotein D expression in cutaneous malignant melanomaEva Miranda, Francisco J. Vizoso, Arancha Martín — 2003
• Apolipoprotein D expression in endometrial carcinomasJulio Vázquez Rojo, Luis O. González, Marı́a L. Lamelas — 2001
• p53 Family Members Regulate the Expression of the Apolipoprotein D Gene*Yasushi Sasaki, H. Negishi, Ryota Koyama — 2009
• Expression and potential role of apolipoprotein D on the death–survival balance of human colorectal cancer cells under oxidative stress conditionsRaquel Bajo‐Grañeras, Jesús Crespo-Sanjuán, Rosa M. García-Centeno — 2013
• The Expression of Apolipoprotein D in Hepatocellular CarcinomaHongxiu Han, Chan-Kum Park — 2010
• Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinomaTohru Utsunomiya, Kazuhiko Ogawa, Keiji Yoshinaga — 2005
• Expression of Two Androgen-Induced Proteins (Pepsinogen C and Apolipoprotein D) in Epithelial Skin Cancers of the EyelidsMaría L. Álvarez, J.J. Barbón, Luis O. González — 2004
• Apolipoprotein D Expression in RetinoblastomaMaría L. Álvarez, J.J. Barbón, Luis O. González — 2003
• A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancerHsin‐Yao Tang, Lynn A. Beer, Tony Chang-Wong — 2011
• Apolipoprotein D Expression in Primary Brain Tumors: Analysis by Quantitative RT-PCR in Formalin-fixed, Paraffin-embedded TissueStephen Hunter, Vijay Varma, Bahig M. Shehata — 2005
• Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.Emily N. Manderson, Anne‐Marie Mes‐Masson, Jaroslav Novák — 2002
• Apo D in Soft Tissue Tumors: A Novel Marker for Dermatofibrosarcoma ProtuberansRobert B. West, Jeff D. Harvell, Sabine C. Linn — 2004
• Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.Stephen Hunter, S WEISS, Che‐Wei Ou — 2005
• Apolipoproteins and cancerLiwen Ren, Jie Yi, Li Wan — 2019
• Molecular comparison of pure ovarian fibroma with serous benign ovarian tumoursSally M. Hunter, Genevieve Dall, Maria Doyle — 2020
• Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variationsWenxin Liu, Qiuying Jiang, Chao Sun — 2022
• A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast CancerRuijun Zhao, Chaoyu Xie, Yu Gong — 2022

Related papers

• Comparison between the usage of immunohistochemistry autostainer and manual operationWU Shang-jin — 2007
• Clinical relevance vs. statistical significance: Using neck outcomes in patients with temporomandibular disorders as an example.Susan Armijo‐Olivo, Sharon Warren, Jorge Fuentes — 2011
• [Is standardization possible in immunohistochemical examination?].Susan L. Kaczorowski, Magdalena Kaczorowska — 1992
• Mass screening to identify babies with dyslipoproteinemia by measuring the levels of apoA-I, apoB and the ratio of apoB to apoA-I on dried blood spotsRie Nakamura, Takao Ohta, Masahiro Migita — 1992
• Specificity of lipid incorporation is determined by sequences in the N-terminal 37 of apoB.Margaretha Carraway, Haya Herscovitz, Vassilis I. Zannis — 2000
• Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene.Rai Ajit K. Srivastava, Neelam Srivastava, Maurizio Averna — 1999
• [The expression and clinical pathological significance of PDCD in laryngocarcinoma].Guofei Feng, Peihua Li, Huihua You — 2011